Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1407 of 6351
-
New trial aims to protect Moms' hearts after preeclampsia
Disease control Recruiting nowThe goal of this clinical trial is to learn if a postpartum bundle intervention can improve cardiometabolic health and lifestyle-related factors in women who have had preeclampsia during their first pregnancy. The main questions it aims to answer are: * Does the 9-month interven…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a smartphone app help stop HIV in young men?
Prevention Recruiting nowMyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed …
Sponsor: Columbia University • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
New lupus pill enters Mid-Stage trial – hope for better control?
Disease control Recruiting nowThis study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill takes on aggressive brain tumors in early trial
Disease control Recruiting nowThis is an open-label, multicenter dose-escalation study to be followed by a dose expansion to define the optimal dose of GLIX1 as monotherapy by reviewing safety and tolerability, disease characteristics and pharmacokinetic profiles and preliminary clinical activity in participa…
Phase 1 • Sponsor: Tetragon Biosciences Ltd • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Simple vitamins may shield kidneys from chemo damage, new study suggests
Disease control Not yet recruitingCisplatin is a widely used chemotherapy drug for many solid tumors (e.g., lung, bladder, ovarian, head and neck cancers). Despite its efficacy, its clinical use is limited by severe side effects, mainly nephrotoxicity, which occurs in \~30% of patients after treatment. Once insid…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowA Phase II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of IBI343 in combination therapy for patients with advanced malignant solid tumors.To evaluate the efficacy and safety of IBI343 in combination therapy for patients with advanced malignant solid…
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New laser microscope could help surgeons save nerves during prostate cancer surgery
Diagnosis Recruiting nowThe goal of this study is to find out whether a new method called "LaserSAFE" can accurately detect cancer at the edge of the prostate (called a positive margin) during prostate surgery. LaserSAFE uses a special microscope in the operating room to quickly scan the prostate after …
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Brain cancer patients get continued access to promising combo therapy in long-term safety study
Disease control Recruiting nowThis clinical trial is a rollover study designed to provide continued access to NBM-BMX and temozolomide (TMZ) for eligible participants with newly diagnosed glioblastoma who have completed the designated treatment in Study NBM-BMX-003 (the parent study), and to evaluate the long…
Phase 1/2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for DMD: Long-Term trial of weekly infusions begins
Disease control By invitation onlyThis open-label extension study aims to evaluate the long-term safety and tolerability of weekly BMN 351 infusions, as well as to assess the effect of BMN 351 on physical function, in participants with DMD who participated in the 351-201 study.
Phase 2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Promising combo aims to shrink tumors in elderly breast cancer patients
Disease control Not yet recruitingEnglish Translation (Professional Medical Version) This study is a multicenter, prospective clinical trial designed to investigate the efficacy and safety of neoadjuvant therapy with trastuzumab plus pertuzumab combined with metronomic vinorelbine chemotherapy in elderly patients…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could your own belly fat fix a stubborn Crohn's fistula?
Disease control Recruiting nowPerianal fistulizing Crohn's disease (pCD) represents a severe phenotype of Crohn's disease, affecting approximately 20-30% of patients and resulting in chronic drainage, recurrent sepsis, impaired continence, and reduced quality of life. Despite optimization of biologics, antibi…
Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI could spot pancreatic cysts more accurately than doctors
Diagnosis Recruiting nowThe aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions) for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound…
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Can a tiny zing at your fingertips wake the brain? new trial aims to find out
Symptom relief Recruiting nowEffective treatment options for disorders of consciousness (DoC) remain limited, and available interventions show heterogeneous efficacy. To date, limited evidences support the use of amantadine and transcranial direct current stimulation in this population. Bloodletting punctur…
Phase 2/3 • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New hope for aggressive lymphoma: triple-drug combo enters first human tests
Disease control Not yet recruitingA Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined with Obinutuzumab in the First-Line Treatment of Newly Diagnosed Intermediate-to-High-Risk Mantle Cell Lymphoma
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test could catch hip disease before It's too late
Diagnosis Recruiting nowOsteonecrosis of the femoral head (ONFH) presents a rapidly progressive natural disease course. Femoral head collapse may occur within two years, ultimately necessitating total hip arthroplasty and imposing a heavy medical and economic burden on patients. Early intervention can s…
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can video games boost brain power in schizophrenia? new trial aims to find out
Disease control Recruiting nowSchizophrenia is a severe and chronic mental disorder that profoundly impacts patients' psychological, social, and occupational functions. Cognitive impairment is a core symptom that severely limits daily living abilities. Systematic rehabilitation is crucial for delaying disease…
Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain-Computer interface targets anxiety in heart patients
Symptom relief Not yet recruitingThis study is a prospective, randomized, sham-controlled, participant- and assessor-blinded, parallel-group clinical trial designed to evaluate the clinical efficacy, mechanistic effects, and safety of right dorsolateral prefrontal cortex (DLPFC) closed-loop functional near-infra…
Sponsor: Shenyang Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Smartphone-Guided weight loss trial aims to boost heart health in obese patients
Disease control Recruiting nowCoronary Heart Disease (CHD) is an ischemic heart disease caused by coronary atherosclerosis, and it is the leading cause of death from cardiovascular diseases worldwide. Weight loss in obese patients can significantly improve metabolic indicators such as dyslipidemia and insulin…
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New CML drug asciminib under Real-World study
Disease control Recruiting nowThe aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients who were either newly diagnosed or previously treated with one ATP-competitive tyrosine kinase inhibito…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Genetic clues to mysterious childhood movement disorders in vietnam
Knowledge-focused Recruiting nowThis observational patient registry aims to describe the clinical phenotypes and genetic findings of Vietnamese children with movement disorders of unknown etiology. Eligible participants are children with clinically confirmed movement disorders after evaluation by pediatric neur…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC